SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041294
Filing Date
2023-11-14
Accepted
2023-11-14 17:10:54
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1208492
2 ex31-1.htm EX-31.1 20070
3 ex31-2.htm EX-31.2 20086
4 ex32-1.htm EX-32.1 8189
5 ex32-2.htm EX-32.1 8569
  Complete submission text file 0001493152-23-041294.txt   5927565

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aim-20230930.xsd EX-101.SCH 46114
7 XBRL CALCULATION FILE aim-20230930_cal.xml EX-101.CAL 54086
8 XBRL DEFINITION FILE aim-20230930_def.xml EX-101.DEF 191926
9 XBRL LABEL FILE aim-20230930_lab.xml EX-101.LAB 369390
10 XBRL PRESENTATION FILE aim-20230930_pre.xml EX-101.PRE 274760
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 964558
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 231407884
SIC: 2836 Biological Products, (No Diagnostic Substances)